Before you discount the results of a DTC genetic test, explore your patient’s reason for undergoing the testing and consider the appropriateness of a referral for medical-grade testing.
Findings support expansion of genetic testing to all women with breast cancer.
A review of the cultural and religious beliefs of Ashkenazi Jewish women that may challenge adherence to breast cancer screening and genetic testing recommendations.
The goal of this study was to determine how molecular features change when PDAC progresses from a primary tumor to metastatic disease.
Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation
A retrospective analysis of genetic testing results at one laboratory reports that reclassifications occurs in approximately one-quarter of tests, resulting in both downgrades and upgrades of variant classifications.
In a randomization of women with early-stage breast cancer, researchers explored the potential benefits of chemotherapy for women whose Oncotype DX RS was midrange.
Investigators conducted a case-control study of 3030 pancreatic cancer patients in an attempt to confirm which genes might render patients susceptible to pancreatic cancer.
Researchers examined interest in MC1R testing in the general population and assessed patterns across demographic and skin cancer risk factors.
The US FDA has approved a consumer test that may indicate increased breast and ovarian cancer risk in some individuals.
